)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Advanced Enzyme Technologies (ADVENZYMES) investor relations material
Advanced Enzyme Technologies Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary13 Nov, 2025
Executive summary
Q2 FY26 revenue reached INR 1,845 million, up 26% year-on-year, with EBITDA up 42% and PAT up 34%; sequentially, EBITDA and PAT grew 6% and 11% respectively.
H1 FY26 revenue was INR 3,704 million, up 23% year-on-year, with EBITDA and PAT up 24%-25%.
Growth was broad-based across all business segments, with human healthcare/nutrition contributing 66% of Q2 revenue, animal healthcare/nutrition 10%, bioprocessing 14%, and specialized manufacturing 10%.
The Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.
Financial highlights
Q2 FY26 revenue: INR 1,845 million (+26% YoY, -1% QoQ); EBITDA: INR 601 million (+42% YoY, +6% QoQ); EBITDA margin: 33%; PAT: INR 447 million (+34% YoY, +11% QoQ); PAT margin: 24%.
H1 FY26 revenue: INR 3,704 million (+23% YoY); EBITDA: INR 1,165 million (+25% YoY); PAT: INR 852 million (+25% YoY); EBITDA margin: 31%; PAT margin: 23%.
EPS for Q2 FY26 was INR 3.87, up 32% year-on-year.
Net profit for Q2 FY26 was INR 404.40 million, up from INR 333.93 million in Q2 FY25.
Subsidiaries ZC Biotech, EWOC, and SISEC reported strong revenue and profit growth year-on-year.
Outlook and guidance
Management maintains mid-teens revenue growth guidance for FY26, citing global uncertainties and tariff impacts.
Focus areas include expanding animal nutrition, probiotics, bio-catalysis, and baking solutions, with new product launches and global distribution.
R&D spending to increase with the new R&D center coming online by end of March, supporting future product launches.
EBITDA margin expected to remain in the 30%-32% range, with PAT margin around 21%-22%, barring further tariff impacts.
The company is monitoring the impact of new US tariffs on enzyme imports from India; as of September 2025, no material impact was observed.
US tariff mitigation plans?
What sustains 30-32% EBITDA margin?
How R&D investment drives long-term growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Advanced Enzyme Technologies earnings date
Q3 25/2611 Feb, 2026
Next Advanced Enzyme Technologies earnings date
Q3 25/2611 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Advanced Enzyme Technologies Limited is an India-based biotechnology company that manufactures and markets enzymes and probiotics. The company supplies products for industries including pharmaceuticals, food and beverage, animal nutrition, and textiles. It operates manufacturing and research facilities across India and internationally. Advanced Enzyme Technologies Limited is headquartered in Thane, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage